223
Views
13
CrossRef citations to date
0
Altmetric
Review

Exploiting the potential of molecular profiling in Parkinson’s disease: current practice and future probabilities

, , &
Pages 1035-1050 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alejandro Bustamante, Teresa Garcia-Berrocoso, Victor Llombart, Alba Simats, Dolors Giralt & Joan Montaner. (2014) Neuroendocrine hormones as prognostic biomarkers in the setting of acute stroke: overcoming the major hurdles. Expert Review of Neurotherapeutics 14:12, pages 1391-1403.
Read now

Articles from other publishers (12)

Mark van den Hurk, Shong Lau, Maria C. Marchetto, Jerome Mertens, Shani Stern, Olga Corti, Alexis Brice, Beate Winner, Jürgen Winkler, Fred H. Gage & Cedric Bardy. (2022) Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neurons. npj Parkinson's Disease 8:1.
Crossref
Marcela Konjevod, Jorge Sáiz, Coral Barbas, Alberto Bergareche, Eva Ardanaz, José Ma Huerta, Ana Vinagre-Aragón, Ma Elena Erro, Ma Dolores Chirlaque, Eunate Abilleira, Jesús Ma Ibarluzea & Pilar Amiano. (2022) A Set of Reliable Samples for the Study of Biomarkers for the Early Diagnosis of Parkinson's Disease. Frontiers in Neurology 13.
Crossref
Chiara Villa & Jong Hyuk Yoon. (2021) Multi-Omics for the Understanding of Brain Diseases. Life 11:11, pages 1202.
Crossref
Anu Paul, Manuel Comabella & Roopali Gandhi. (2019) Biomarkers in Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine 9:3, pages a029058.
Crossref
Diane B. Miller & James P. O’Callaghan. (2015) Biomarkers of Parkinson’s disease: Present and future. Metabolism 64:3, pages S40-S46.
Crossref
Ai-hua Zhang, Hui Sun & Xi-jun Wang. (2013) Recent advances in metabolomics in neurological disease, and future perspectives. Analytical and Bioanalytical Chemistry 405:25, pages 8143-8150.
Crossref
Amy W. Amara & David G. Standaert. (2013) Metabolomics and the search for biomarkers in Parkinson's disease. Movement Disorders 28:12, pages 1620-1621.
Crossref
Sushil Sharma, Carolyn Seungyoun Moon, Azza Khogali, Ali Haidous, Anthony Chabenne, Comfort Ojo, Miriana Jelebinkov, Yousef Kurdi & Manuchair Ebadi. (2013) Biomarkers in Parkinson’s disease (recent update). Neurochemistry International 63:3, pages 201-229.
Crossref
Sharawan Yadav, Anubhuti Dixit, Sonal Agrawal, Ashish Singh, Garima Srivastava, Anand Kumar Singh, Pramod Kumar Srivastava, Om Prakash & Mahendra Pratap Singh. (2012) Rodent Models and Contemporary Molecular Techniques: Notable Feats yet Incomplete Explanations of Parkinson’s Disease Pathogenesis. Molecular Neurobiology 46:2, pages 495-512.
Crossref
Patrick A. Lewis & Mark R. Cookson. (2012) Gene expression in the Parkinson's disease brain. Brain Research Bulletin 88:4, pages 302-312.
Crossref
I. Ferrer, I. López-Gonzalez, M. Carmona, E. Dalfó, A. Pujol & A. Martínez. (2012) Neurochemistry and the non-motor aspects of PD. Neurobiology of Disease 46:3, pages 508-526.
Crossref
Alan Mackay-Sim, George Mellick & Stephen Wood. 2011. Biomarkers of Neurological and Psychiatric Disease. Biomarkers of Neurological and Psychiatric Disease 239 257 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.